Q fever laboratory tests

Q fever Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Q fever from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary prevention
Secondary prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Q fever laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Q fever laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Q fever laboratory tests
CDC on Q fever laboratory tests
Q fever laboratory tests in the news
Blogs on Q fever laboratory tests
Directions to Hospitals Treating Q fever
Risk calculators and risk factors for Q fever laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Lab tests:

Serologic testing for Q fever:

• Indirect immunofluorescence (IIF) is the method of choice for antibody detection and is preferred over ELISA and complement fixation.
• Antibodies starts to be detected after 7-14 days of infection with most patients testing positive by the third week.
• Anti phase II antibodies are tested first. If positive, anti phase I antibodies are tested.
• After acute infection, serologic follow up for serum anti phase I IgG antibodies. The test is done twice every 3 months for 2 years. If it's positive, Transesophageal echo should be done to rule out endocarditis.
• All serologic test results should be used in the context of clinical data because false positive test results are seen in many other diseases (e.g. leptospirosis).

Polymerase chain reaction (PCR):

• PCR can be used to detect C. brutenii DNA in cultures and clinical samples.
• PCR is positive in the first week of infection, thus it can be used to diagnose Q fever in patients who are serologically negative in the early stages of the disease.
• Quantitative PCR also can be used in patients whom anti phase II IgG antibodies are persistently positive to detect chronic Q fever.

Cultures:

• C. brutenii doesn’t grow on ordinary blood cultures but can be cultivated on special media as embryonated eggs or cell culture.
• C. brutenii is extremely infectious and samples should be handled with caution.

Liver function tests:

• 2-3 fold increase in AST and ALT is seen in most of the patients.